SCHEMBL6835649

SCHEMBL6835649

CC(C)[Si](c1cc(C(=O)Nc2ccc(C#N)cc2C(=O)O)no1)(C(C)C)C(C)C

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALB P02768 2/20 0.43
KMT2A Q03164 4/20 0.40
MAP2K1 Q02750 1/20 0.39
STING1 Q86WV6 1/20 0.39
ALDH1A1 P00352 3/20 0.39
PKM P14618 1/20 0.39
RXFP1 Q9HBX9 1/20 0.39
SMN1; SMN2 Q16637 5/20 0.38
KDM4E B2RXH2 1/20 0.38
LMNA P02545 1/20 0.38
MEN1 O00255 2/20 0.37
PYGL P06737 1/20 0.37
PYGM P11217 1/20 0.37
F10 P00742 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
NPC1 O15118 1/20 0.36
HPGD P15428 1/20 0.36
RAB9A P51151 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6830333 0.83 MAPT (0.49) ALBALDH1A1SMN1; SMN2KDM4ENPC1
SCHEMBL6818393 0.80 ALDH1A1 (0.48) ALBALDH1A1PKMRXFP1SMN1; SMN2
SCHEMBL6822132 0.79 ALB (0.45) ALBKMT2AMAP2K1STING1ALDH1A1
SCHEMBL6835713 0.79 ALB (0.45) ALBKMT2AMAP2K1STING1ALDH1A1
SCHEMBL6813729 0.78 TDP1 (0.55) KMT2AALDH1A1RXFP1SMN1; SMN2KDM4E
SCHEMBL6834026 0.76 KMT2A (0.46) KMT2AALDH1A1RXFP1SMN1; SMN2KDM4E
SCHEMBL6818610 0.76 FTO (0.43) ALBKMT2AALDH1A1RXFP1SMN1; SMN2
SCHEMBL6833783 0.76 HSD17B10 (0.49) KMT2AALDH1A1PKMRXFP1SMN1; SMN2
SCHEMBL6818740 0.75 RXFP1 (0.71) KMT2AALDH1A1RXFP1SMN1; SMN2MEN1
SCHEMBL6818204 0.75 KDM4E (0.46) ALBKMT2AALDH1A1PKMRXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040110802-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-06-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040110802-A1 Antibacterial benzoic acid derivatives GABRD, GABBR1, GABRA1 ALB 1417/4885KMT2A 2853/4885MAP2K1 4675/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.